1. Home
  2. THTX vs VNRX Comparison

THTX vs VNRX Comparison

Compare THTX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • VNRX
  • Stock Information
  • Founded
  • THTX 1993
  • VNRX N/A
  • Country
  • THTX Canada
  • VNRX United States
  • Employees
  • THTX N/A
  • VNRX N/A
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • THTX Health Care
  • VNRX Health Care
  • Exchange
  • THTX Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • THTX 56.1M
  • VNRX 67.2M
  • IPO Year
  • THTX N/A
  • VNRX N/A
  • Fundamental
  • Price
  • THTX $1.18
  • VNRX $0.68
  • Analyst Decision
  • THTX Hold
  • VNRX Strong Buy
  • Analyst Count
  • THTX 1
  • VNRX 4
  • Target Price
  • THTX N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • THTX 29.7K
  • VNRX 135.1K
  • Earning Date
  • THTX 10-10-2024
  • VNRX 11-14-2024
  • Dividend Yield
  • THTX N/A
  • VNRX N/A
  • EPS Growth
  • THTX N/A
  • VNRX N/A
  • EPS
  • THTX N/A
  • VNRX N/A
  • Revenue
  • THTX $84,316,000.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • THTX $5.60
  • VNRX $180.66
  • Revenue Next Year
  • THTX $4.62
  • VNRX $558.69
  • P/E Ratio
  • THTX N/A
  • VNRX N/A
  • Revenue Growth
  • THTX 5.75
  • VNRX 97.50
  • 52 Week Low
  • THTX $1.08
  • VNRX $0.43
  • 52 Week High
  • THTX $2.58
  • VNRX $1.23
  • Technical
  • Relative Strength Index (RSI)
  • THTX 40.63
  • VNRX 50.19
  • Support Level
  • THTX $1.21
  • VNRX $0.55
  • Resistance Level
  • THTX $1.28
  • VNRX $0.80
  • Average True Range (ATR)
  • THTX 0.07
  • VNRX 0.07
  • MACD
  • THTX -0.01
  • VNRX 0.01
  • Stochastic Oscillator
  • THTX 9.37
  • VNRX 52.00

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: